Open AccessBuprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum
Author(s) -
Caitlin E. Martin,
Caroline Shadowen,
Bhushan Thakkar,
Travis Oakes,
Tamas S. Gal,
F. Gerard Moeller
Publication year - 2020
Publication title -
current treatment options in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.497
H-Index - 15
ISSN - 2196-3061
DOI - 10.1007/s40501-020-00221-z
Subject(s) - buprenorphine , dosing , pregnancy , medicine , opioid use disorder , obstetrics , retrospective cohort study , postpartum period , intensive care medicine , opioid , receptor , biology , genetics
Opioid-related deaths are a leading cause of mortality during pregnancy through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet expert opinion on its dosing through the perinatal period is limited. We provide a review of the current clinical literature on buprenorphine dosing during pregnancy through 12 months postpartum. and present data from a retrospective chart review of patients at our institution describing trends in buprenorphine dosing during pregnancy and postpartum. Utilizing this information, we synthesize findings to provide clinical recommendations for providers.